Search Results for: FCER1G

93 interactions involving FCER1G - Fc epsilon receptor Ig found:

Sort by: Symbol Number of Pathways Number of Drugs Number of Diseases
Novel Symbol Description Pathways Hide Drugs Hide Diseases Hide
SLC1A1 solute carrier family 1 member 1
  • Glutamate Neurotransmitter Release Cycle
  • Defective SLC1A1 is implicated in schizophrenia 18 (SCZD18) and dicarboxylic aminoaciduria (DCBXA)
  • SLC-mediated transport of amino acids
  • Aspartic acid
  • Glutamic acid
  • Dicarboxylic aminoaciduria
SLC30A8 solute carrier family 30 member 8
  • Insulin processing
  • Zinc efflux and compartmentalization by the SLC30 family
  • Type II diabetes mellitus
SLC35G2 solute carrier family 35 member G2
SLC38A7 solute carrier family 38 member 7
SLC39A2 solute carrier family 39 member 2
  • Zinc influx into cells by the SLC39 gene family
SLC39A9 solute carrier family 39 member 9
SLC7A1 solute carrier family 7 member 1
  • Amino acid transport across the plasma membrane
  • Lysine
  • Arginine
  • Ornithine
SLC7A14 solute carrier family 7 member 14
SMIM1 small integral membrane protein 1 (Vel blood group)
STX12 syntaxin 12
SYK spleen associated tyrosine kinase
  • GPVI-mediated activation cascade
  • GPVI-mediated activation cascade
  • FCGR activation
  • FCGR activation
  • Regulation of actin dynamics for phagocytic cup formation
  • Role of phospholipids in phagocytosis
  • DAP12 signaling
  • Fc epsilon receptor (FCERI) signaling
  • Fc epsilon receptor (FCERI) signaling
  • Role of LAT2/NTAL/LAB on calcium mobilization
  • Role of LAT2/NTAL/LAB on calcium mobilization
  • FCERI mediated MAPK activation
  • FCERI mediated Ca+2 mobilization
  • FCERI mediated Ca+2 mobilization
  • Integrin signaling
  • CLEC7A (Dectin-1) signaling
  • Dectin-2 family
  • Dectin-2 family
  • Interleukin-2 signaling
  • Regulation of signaling by CBL
  • Regulation of signaling by CBL
  • FCGR3A-mediated IL10 synthesis
  • FCGR3A-mediated phagocytosis
  • Signaling by CSF3 (G-CSF)
  • Signaling by CSF3 (G-CSF)
  • Potential therapeutics for SARS
  • Inactivation of CSF3 (G-CSF) signaling
  • Inactivation of CSF3 (G-CSF) signaling
  • FLT3 signaling through SRC family kinases
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Staurosporine
  • N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide
  • Tamatinib
  • 2-{2-[(3,5-dimethylphenyl)amino]pyrimidin-4-yl}-N-[(1S)-2-hydroxy-1-methylethyl]-4-methyl-1,3-thiazole-5-carboxamide
  • 2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide
  • Ellagic acid
  • Fostamatinib
  • Entospletinib
SYNJ2BP synaptojanin 2 binding protein
SYS1 SYS1 golgi trafficking protein
  • Retrograde transport at the Trans-Golgi-Network
THBD thrombomodulin
  • Common Pathway of Fibrin Clot Formation
  • Cell surface interactions at the vascular wall
  • Drotrecogin alfa
  • Ibuprofen
  • Dexibuprofen
  • Inherited thrombophilia
TMEM107 transmembrane protein 107
TMEM120B transmembrane protein 120B
TMEM140 transmembrane protein 140
TMEM14B transmembrane protein 14B
TMEM179B transmembrane protein 179B
  • Neutrophil degranulation
TMEM19 transmembrane protein 19

Page 4 out of 5 pages